Page last updated: 2024-10-21

phenytoin and Carcinoma, Intraductal, Noninfiltrating

phenytoin has been researched along with Carcinoma, Intraductal, Noninfiltrating in 1 studies

Carcinoma, Intraductal, Noninfiltrating: A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.

Research Excerpts

ExcerptRelevanceReference
"A case of erythema multiforme associated with prophylactic use of phenytoin during cranial radiation therapy is reported."7.74Erythema multiforme associated with prophylactic use of phenytoin during cranial radiation therapy. ( Barbosa, LA; Teixeira, CR, 2008)
"A case of erythema multiforme associated with prophylactic use of phenytoin during cranial radiation therapy is reported."3.74Erythema multiforme associated with prophylactic use of phenytoin during cranial radiation therapy. ( Barbosa, LA; Teixeira, CR, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbosa, LA1
Teixeira, CR1

Other Studies

1 other study available for phenytoin and Carcinoma, Intraductal, Noninfiltrating

ArticleYear
Erythema multiforme associated with prophylactic use of phenytoin during cranial radiation therapy.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Jun-01, Volume: 65, Issue:11

    Topics: Anticonvulsants; Brain Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cranial

2008